Safety of rFVIIa in hemodynamically unstable polytrauma patients with traumatic brain injury: post hoc analysis of 30 patients from a prospective, randomized, placebo-controlled, double-blind clinical trial

BACKGROUND: Trauma is a leading cause of mortality and morbidity, with traumatic brain injury (TBI) and uncontrolled hemorrhage responsible for the majority of these deaths. Recombinant activated factor VIIa (rFVIIa) is being investigated as an adjunctive hemostatic treatment for bleeding refractory...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kluger, Yoram, Riou, Bruno, Rossaint, Rolf, Rizoli, Sandro B, Boffard, Kenneth David, Choong, Philip Iau Tsau, Warren, Brian, Tillinger, Michael
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2007
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2206502/
https://ncbi.nlm.nih.gov/pubmed/17686152
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/cc6092
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados